INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 204 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2015. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $6,830,000 | +62.6% | 43,782 | +146.7% | 0.12% | -26.1% |
| Q3 2014 | $4,200,000 | +178.3% | 17,745 | +178.3% | 0.16% | +180.4% |
| Q2 2014 | $1,509,000 | +8.7% | 6,376 | +51.4% | 0.06% | +1.8% |
| Q1 2014 | $1,388,000 | -1.5% | 4,210 | -79.6% | 0.06% | -28.6% |
| Q4 2013 | $1,409,000 | -29.5% | 20,636 | -28.7% | 0.08% | -40.3% |
| Q3 2013 | $1,998,000 | -11.4% | 28,951 | -42.4% | 0.13% | -25.4% |
| Q2 2013 | $2,255,000 | – | 50,300 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |